ENZY News Alert Enzymotec Ltd (ENZY) 7.48 12/25/2014 04:09:5

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Enzymotec Ltd (ENZY) 7.48 $ENZY

Tracking John Paulson's Paulson & Company Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Thu Nov 20, 12:49AM CST

RKT: 61.26 (-0.41), KOG: 6.56 (-0.39), MEAS: 86.00 (+0.01), HHC: 133.21 (+0.49), AET: 89.59 (+0.14), DLPH: 73.45 (-0.42), DLTR: 69.86 (-0.20), AEM: 23.65 (+0.65), AUXL: 34.40 (+0.18), DG: 69.86 (+0.31), ABBV: 66.21 (+1.86), DXM: 9.06 (+0.12), MNK: 97.84 (-0.29), ATHL: 58.40 (unch), NCQ: 0.55 (unch), COV: 103.35 (+0.57), AU: 8.39 (+0.24), MYL: 56.97 (+0.39), IAG: 2.41 (+0.06), FDO: 79.14 (-0.01), MGM: 20.77 (-0.17), GNW: 8.40 (+0.01), HIG: 42.13 (-0.12), NG: 2.82 (+0.10), EQIX: 233.16 (+1.18), HSH: 62.96 (unch), OAS: 16.66 (-1.05), PETM: 81.16 (+0.03), ACT: 254.20 (-1.68), MDT: 74.08 (+0.31), BPOP: 33.68 (+0.09), ENZY: 7.48 (-0.01), FCX: 22.91 (+0.07), GFI: 4.37 (+0.13), CZR: 15.44 (+0.20), CVC: 20.60 (+0.17), CIE: 8.79 (-0.25), CACQ: 9.96 (+0.12), AGN: 210.12 (+0.95), ECA: 13.73 (-0.03), FCH: 10.80 (-0.06), R: 93.37 (-0.15), DTV: 86.82 (-0.05), KMDA: 3.57 (-0.03), ANV: 0.88 (+0.02), MOVE: 20.95 (-0.03), BAC: 17.98 (+0.05), GRFS: 34.26 (+0.33), POST: 42.51 (+0.49), HCA: 74.89 (-0.11), RDN: 16.78 (+0.18), BEE: 13.55 (-0.01), CPWR: 10.35 (+0.01), GLD: 112.77 (+0.03), RLGY: 43.91 (+0.39), MTG: 9.31 (+0.06), HMHC: 20.75 (-0.03), CMCSA: 58.07 (+0.17), CBS: 55.70 (-0.13), BABA: 105.95 (+0.43)

Enzymotec Ltd. (ENZY) in Focus: Stock Rallies 15% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 7:44AM CST
Enzymotec Ltd. (ENZY) was a big mover last session, as the company saw its shares surge 15% on the day.
ICUI: 83.38 (+1.63), ABAX: 58.48 (+0.22), GWPH: 68.08 (+1.82), ENZY: 7.48 (-0.01)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 11:47AM CST

CADC: 4.95 (+0.05), ANV: 0.88 (+0.02), BONE: 2.59 (-0.02), WLH: 19.34 (-0.05), CLDX: 17.08 (-0.18), ENZY: 7.48 (-0.01), TGEN: 5.20 (+0.05), CHOP: 1.58 (unch), MSBF: 10.15 (+0.05), NVGN: 2.40 (-0.09), DWA: 22.72 (+0.05), WHX: 1.86 (-0.03), VYFC: 19.73 (-0.07), VGGL: 2.89 (+0.04), SNSS: 2.48 (-0.03), DNR: 8.15 (-0.18), MOBI: 4.09 (+0.21), VPCO: 1.30 (-0.01), FOLD: 7.94 (+0.06), ATEA: 1.64 (-0.05)

Enzymotec's (ENZY) CEO Dr. Ariel Katz on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 12:50PM CST

ENZY: 7.48 (-0.01)

Enzymotec beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 6:34AM CST

ENZY: 7.48 (-0.01)

Enzymotec Ltd. Reports Third Quarter 2014 Unaudited Financial Results
GlobeNewswire - Thu Nov 13, 6:30AM CST
Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today reported its financial results for the third quarter ended September 30, 2014.
ENZY: 7.48 (-0.01)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 4:30PM CST

KSS: 60.46 (-1.08), VTNR: 3.32 (-0.08), TYC: 44.70 (+0.33), SPH: 43.14 (-0.20), FLY: 13.01 (+0.12), ENZY: 7.48 (-0.01), RWLK: 21.66 (+0.11), WMT: 86.43 (-0.23), RSTI: 29.46 (+0.32), SBH: 30.89 (-0.29), HP: 67.25 (-0.66), GIB: 38.39 (-0.16), TDG: 200.61 (+2.35), CLFD: 12.75 (-0.01), HIMX: 8.07 (+0.06), VIAB: 76.89 (-0.38), MMS: 54.94 (+0.06)

Enzymotec Ltd. Initiates Clinical Study of Vayarin(R) in Adult ADHD
GlobeNewswire - Tue Nov 11, 7:38AM CST
Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer, and marketer of innovative bio-active lipid based nutritional ingredients and medical foods, today announced the initiation of a clinical study to evaluate the efficacy of Vayarin(R) in adults with Attention Deficit Hyperactivity Disorder, or ADHD.
ENZY: 7.48 (-0.01)

Enzymotec to Report Third Quarter Fiscal Year 2014 Financial Results
GlobeNewswire - Thu Oct 30, 7:30AM CDT
Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that the Company will release financial results for the third quarter ended September 30, 2014 on Thursday, November 13, 2014, before the market opens. Following the release, Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Vice President and Chief Financial Officer will host a conference call to review the financial results.
ENZY: 7.48 (-0.01)

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Class Action Involving Enzymotec Ltd. and a Lead Plaintiff Deadline of November 4, 2014 -- ENZY
GlobeNewswire - Wed Oct 29, 11:17AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Enzymotec Ltd. ("Enzymotec" or the "Company" (Nasdaq:ENZY) common stock pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or investors who purchased shares on the open market between September 27, 2013 and August 4, 2014.
ENZY: 7.48 (-0.01)

INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Enzymotec Ltd.
Business Wire - Wed Oct 29, 9:30AM CDT
Glancy Binkow & Goldberg LLP reminds investors of Enzymotec Ltd. ("Enzymotec" or the "Company" (NASDAQ:ENZY) that all purchasers of the Company's securities pursuant and/or traceable to the Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" , have until November 4, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit.
ENZY: 7.48 (-0.01)

NOV. 4th DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Enzymotec Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of November 4, 2014
Business Wire - Mon Oct 27, 2:45PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Enzymotec Ltd. ("Enzymotec" or the "Company" (Nasdaq:ENZY) common stock pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or investors who purchased shares on the open market between September 27, 2013 and August 4, 2014.
ENZY: 7.48 (-0.01)

Which Stocks Hurt Billionaire Portfolios the Most in 2014?
at The Street - Mon Oct 27, 7:48AM CDT
See the stocks that have performed the worst for 19 billionaires who made their money investing.
BID: 43.31 (+0.01), CBI: 41.94 (-0.17), MDR: 2.78 (+0.01), DLIA: 0.01 (unch), EOPN: 9.37 (-0.02), PGEM: 13.19 (+0.06), ENZY: 7.48 (-0.01), GNC: 46.10 (-0.29), AMCC: 6.63 (+0.09), HHC: 133.21 (+0.49), LL: 63.91 (-0.41), VLTC: 0.69 (-0.01), CZR: 15.44 (+0.20), SNSS: 2.48 (-0.03), TWER: 1.78 (+0.07), SHOS: 11.96 (+0.23), DRYS: 1.20 (-0.04), CREE: 32.64 (+0.08)

ENZYMOTEC SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Enzymotec Ltd. -- ENZY
GlobeNewswire - Sat Oct 25, 4:49PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 4, 2014 to file lead plaintiff applications in a securities class action lawsuit against Enzymotec Ltd. (Nasdaq:ENZY), if they purchased the Company's securities in connection with the Company's initial public offering ("IPO" on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" . This action is pending in the United States District Court for the District of New Jersey.
ENZY: 7.48 (-0.01)

UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Enzymotec Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of November 4, 2014
Business Wire - Tue Oct 21, 11:52AM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Enzymotec Ltd. ("Enzymotec" or the "Company" (Nasdaq:ENZY) common stock pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or investors who purchased shares on the open market between September 27, 2013 and August 4, 2014.
ENZY: 7.48 (-0.01)

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against Enzymotec Ltd.
Business Wire - Thu Oct 16, 9:32AM CDT
Law Offices of Howard G. Smith reminds investors that purchasers of the securities of Enzymotec Ltd. ("Enzymotec" or the "Company" (NASDAQ:ENZY) pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" , have until November 4, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit.
ENZY: 7.48 (-0.01)

UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Enzymotec Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of November 4, 2014 -- ENZY
PR Newswire - Mon Oct 06, 1:33PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Enzymotec Ltd. ("Enzymotec" or the "Company" (Nasdaq: ENZY) common stock pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or investors who purchased shares on the open market between September 27, 2013 and August 4, 2014.
ENZY: 7.48 (-0.01)

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Enzymotec Ltd. to Contact Brower Piven Before the November 4, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- ENZY
GlobeNewswire - Sat Oct 04, 7:00AM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Enzymotec Ltd. ("Enzymotec" or the "Company" (Nasdaq:ENZY) securities pursuant and/or traceable to the Company's Registration Statement and Prospectus ("Offering Documents" issued in connection with the Company's initial public offering on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" .
ENZY: 7.48 (-0.01)

ENZYMOTEC SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Enzymotec Ltd.
Business Wire - Fri Oct 03, 5:22PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 4, 2014 to file lead plaintiff applications in a securities class action lawsuit against Enzymotec Ltd. (Nasdaq: ENZY), if they purchased the Company's securities in connection with the Company's initial public offering ("IPO" on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" . This action is pending in the United States District Court for the District of New Jersey.
ENZY: 7.48 (-0.01)

EQUITY ALERT: The Rosen Law Firm Reminds Enzymotec Ltd. Investors of Important Class Action Deadline -- ENZY
GlobeNewswire - Thu Oct 02, 1:13PM CDT
The Rosen Law Firm reminds purchasers of Enzymotec Ltd. securities (Nasdaq:ENZY) during the period from September 27, 2013 through August 4, 2014, of the important November 4, 2014 class action deadline.
ENZY: 7.48 (-0.01)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

CASEKOO's Montana Story Makes Brand Purpose Personal

Updated Category News Views 45

A blurry Montana kitchen, not a glossy product render, is doing the heavy lifting for CASEKOO this Thanksgiving. That is either a smart bit of brand discipline or a sentimental detour, depending on whether the company can make people feel something without losing sight of why they bought a phone case in the first place. Warmth Takes the Place of Hardware CASEKOO's new...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 74

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 160

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 78

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
iHeart's 65% Plunge Brings a Fraud Probe Into Focus

Updated Category News Views 71

November 10 did not merely bruise iHeartMedia shareholders; it left the stock closing at $0.61 after a decline of more than 65%. That kind of move gets everybody’s attention, including plaintiffs’ lawyers, and Wolf Haldenstein Adler Freeman & Herz LLP has opened an investigation into potential securities fraud claims involving iHeartMedia, its officers, and its...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 159

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 45

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
TEN Holdings Raises $1.0 Million as Dilution Looms

Updated Category News Views 66

A Small Raise With a Loud Message Nothing says “we need room to breathe” quite like selling 1,492,500 new shares for $0.67 apiece. TEN Holdings closed a roughly $1.0 million gross equity offering on November 20, 2026, and investors in NASDAQ:XHLD ought to look at this for what it is: a modest cash infusion that comes with immediate dilution. The company gets capital;...

Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification

Updated Category News Views 95

Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights into Carvana's Growing Options Market Activity

Updated Category News Views 105

Carvana's Options Market Activity Investors with substantial capital are displaying a bullish sentiment towards Carvana Co (NYSE: CVNA). This developing trend in the options market is noteworthy and shouldn't be overlooked by market participants. Recent analyses have revealed an intriguing series of activities that hint at significant upcoming developments for Carvana....

Continue Reading
Road Warrior Expands Network with Big Acquisitions

Updated Category News Views 30

A Heavy-Duty Play: Road Warrior's Big Moves You might think in the world of heavy-duty parts and service, things move like a freight train—slow and steady. But here comes Road Warrior Parts & Service, full steam ahead with a string of acquisitions that are shaking up the landscape. If you've been snoozing on this sector, it's time to wake up. The Acquisitions That Are...

Continue Reading
Foresight Group Commences Strategic Share Buyback Programme

Updated Category News Views 358

Foresight Group Commences Strategic Share Buyback Programme Foresight Group Holdings Limited (LSE: FSG), a well-respected leader in investment management for real assets, is pleased to announce a new initiative as part of its ongoing commitment to creating shareholder value. This new share buyback programme, announced recently, underscores its proactive approach to...

Continue Reading
Carvana's New Delivery Service Lifts Stock Prices Significantly

Updated Category News Views 164

Overview of Carvana's Recent Stock Movement Carvana Co (NYSE: CVNA) has seen its stock rise as it introduces new service options. Recently, the company extended its same-day vehicle delivery feature to customers in the San Diego area, marking a significant enhancement in its operations. By allowing locals to receive their purchased vehicles on the same day they place an...

Continue Reading
AI-Powered Travel Transformation in Norway Revealed

Updated Category News Views 130

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Continue Reading